You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME/CE

Managing Pain Patients Who Abuse Prescription Drugs

  • Authors: Gayathri J. Dowling, PhD; Richard A. Denisco, MD
  • CME/CE Released: 9/26/2012; Reviewed and Renewed: 10/2/2014
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 10/2/2015
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care providers, neurologists, anesthesiologists, pain specialists, obstetrician/gynecologists, orthopedists, nurse practitioners, nurses and other healthcare practitioners who manage patients with chronic pain.

The goal of this activity is to describe the symptoms and prevalence of opioid addiction and dependence in patients with chronic pain, and the steps clinicians can take to screen for, prevent, and treat such these conditions.

Upon completion of this activity, participants will be able to:

  1. Develop strategies to assess and monitor patients taking opioids for abuse and potential diversion of medication
  2. Propose communication strategies to engage patients in dialog focused on treatment of prescription drug abuse or addiction
  3. Formulate treatment management and possible referral plans to prevent and address opioid addiction in patients with a diagnosis of chronic pain


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Gayathri J. Dowling, PhD

    Acting Chief, Science Policy Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

    Disclosures

    Disclosure: Gayathri J. Dowling, PhD has disclosed no relevant financial relationships.

    Dr Dowling does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Dowling does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Richard A. Denisco, MD

    Medical Officer, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

    Disclosures

    Disclosure: Richard A. Densico, MD, has disclosed no relevant financial relationships.

    Dr. Denisco does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Denisco does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Jane Lowers

    Group Scientific Director, Medscape LLC

    Disclosures

    Disclosure: Jane Lowers has disclosed no relevant financial relationships.

  • Colleen Quinn

    Clinical Editor, Medscape, LLC

    Disclosures

    Disclosure: Colleen Quinn has disclosed no relevant financial relationships.

Writer(s)

  • Lynne Kolton Schneider, PhD

    Freelance writer, Boca Raton, Florida

    Disclosures

    Disclosure: Lynne Kolton Schneider has disclosed no relevant financial relationships.

Additional Planners/Reviewers

  • Robert Carroll, PhD, RN

    Project director, IQ Solutions, Rockville, MD

    Disclosures

    Disclosure: Robert Carroll, PhD, RN, has disclosed no relevant financial relationships.

  • Denise Crute, MA

    Director of training, IQ Solutions, Rockville, MD

    Disclosures

    Disclosure: Denise Crute, MA has disclosed no relevant financial relationships.

  • Bill H. McCarberg, MD

    Primary Care Physician, Adjunct Assistant Clinical Professor, University of California, San Diego; Founder, Chronic Pain Management Program, Kaiser Permanente, San Diego, California

    Disclosures

    Disclosure: Bill McCarberg, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: PriCara; Forest Laboratories, Inc.; Endo Pharmaceuticals; Sucampo Pharmaceuticals, Inc.; NeurogesX, Inc.; Teva Pharmaceuticals; Insys Therapeutics, Inc; QRX Pharma Ltd; Salix Pharmaceuticals, Inc.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 1.75 contact hour(s) of continuing nursing education for RNs and APNs; 1.75 of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME/CE

Managing Pain Patients Who Abuse Prescription Drugs

Authors: Gayathri J. Dowling, PhD; Richard A. Denisco, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME/CE Released: 9/26/2012; Reviewed and Renewed: 10/2/2014

Valid for credit through: 10/2/2015

processing....

The following test-and-teach case is an educational activity modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will see whether you answered correctly and can then read evidence-based information that supports the most appropriate answer choice. Please note that these questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the case, there will be a short posttest assessment based on material covered in the activity.

Case Presentation

Edward, a 52-year-old warehouse employee, injured his back at home getting ready for a move out of state. It is now 2 months later and he is in your office as a new patient. He describes the pain at 7/10, aching in the center of the back without radiation, and no numbness or weakness and no bowel or bladder dysfunction. The pain is worse with bending, cough, or straining with bowel movements.

You have no chart, but the patient describes an initial treatment plan by a prior provider consisting of ibuprofen, tizanidine, ice, heat, stretching, and later physical therapy. He was seen by a physiatrist after a magentic resonance imaging (MRI) showed multilevel disc disease without encroachment. An epidural steroid injection under fluoroscopy did not help to alleviate his pain. Edward is now unemployed and spends much of his day in bed due to continued disabling pain, even though he's on hydrocodone/acetaminophen 10/325 mg 6 pills a day. He currently appears sleepy with diminished affect and is asking for something stronger than the hydrocodone.

The physical exam shows tight muscles in the low back with diffuse tenderness and triggering of the pain down the right leg. His range of motion is restricted by pain, with a negative neurologic exam including a normal straight leg raise. Provocative testing of the sacroiliac joint and piriformis muscle are negative.

  • Print